Phenotypical and Molecular Characterization of Acinetobacter baumannii Isolated from Hospitalized Patients During the COVID-19 Pandemic in Brazil
Authors:
- Paula Araujo de SouzaPSPaula Araujo de Souza
- Milena Cristina Nunes dos SantosMSMilena Cristina Nunes dos Santos
- Rebeca Vitória da Silva Lage de MirandaRMRebeca Vitória da Silva Lage de Miranda
- Luciana Veloso da CostaLCLuciana Veloso da Costa
- Raphael Paiva Paschoal da SilvaRSRaphael Paiva Paschoal da Silva
- Cátia Aparecida Chaia de MirandaCMCátia Aparecida Chaia de Miranda
- Greice Maria Silva da ConceiçãoGCGreice Maria Silva da Conceição
- Stephen James ForsytheSFStephen James Forsythe
- Maria Helena Simões Villas BôasMBMaria Helena Simões Villas Bôas
- Marcelo Luiz Lima BrandãoMBMarcelo Luiz Lima Brandão
Open Access
Abstract
The goal of the present study was to analyze Acinetobacter baumannii strains isolated from hospitalized patients in the period of the COVID-19 pandemic by phenotypic and molecular methods and evaluate their antimicrobial resistance patterns and biofilm production. Forty-seven strains were isolated in 2021–2022 from a hospital in Brazil, and were identified by VITEK®2, MALDI-TOF/MS (VITEK MS® and MALDI Biotyper®), and 16S rRNA sequencing. Fourier-transform infrared (FTIR) spectroscopy was applied for typing and antimicrobial susceptibility testing (AST). In addition, biofilm formation and disinfectant tolerance tests were used. All methods accurately identified all the A. baumannii strains. FTIR typing identified 23 different profiles and 11 clusters, as well as differentiated between the strains from patients with and without COVID-19. Most strains exhibited resistance to the drugs tested, 91.5% of the strains were classified as XDR, 6.4% of the strains were MDR and only 1 strain was classified as non-MDR. Over half of the strains (n = 27, 57.4%) produced biofilms on polystyrene. Sodium hypochlorite (1.0%/15 min) was the best option for effective disinfection. Overall, this study will lay the foundation for further research on effective cleaning protocols for the eradication of A. baumannii biofilms, as well as the use of FTIR for pathogen surveillance in healthcare settings.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (CNPq/MCTI/FNDCT No 18/2021, E-26/210.616/2024, 001)
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (Faperj) (CNPq/MCTI/FNDCT No 18/2021, E-26/210.616/2024, 001)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CNPq/MCTI/FNDCT No 18/2021, E-26/210.616/2024, 001)
This publication has 36 references indexed in Scilit:
- Acinetobacter baumannii Biofilm Formation: Association with Antimicrobial Resistance and Prolonged Survival under DesiccationCurrent Microbiology, 2022
- ESKAPE bacteria characterization reveals the presence of Acinetobacter baumannii and Pseudomonas aeruginosa outbreaks in COVID-19/VAP patientsAmerican Journal of Infection Control, 2022
- Fourier transform infrared spectroscopy as a new tool for surveillance in local stewardship antimicrobial program: a retrospective study in a nosocomial Acinetobacter baumannii outbreakBrazilian Journal of Microbiology, 2022
- Elimination of healthcare-associated Acinetobacter baumannii infection in a highly endemic regionInternational Journal of Infectious Diseases, 2022
- Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitalsMolecular Biology Reports, 2021
- Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unitInfection, 2021
- Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- Species identification within Acinetobacter calcoaceticus–baumannii complex using MALDI-TOF MSJournal of Microbiological Methods, 2015
- Trimethoprim/sulfamethoxazole for Acinetobacter spp.: A review of current microbiological and clinical evidenceInternational Journal of Antimicrobial Agents, 2015
- Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistanceJournal of Infection, 2015